Clinical Trial Update: Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FIAsp with insulin aspart both co-administered with insulin detemir in adults with Type 1 diabetes; results completed and posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)
• Insulin aspart (insulin aspart)
• Insulin detemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2018-01-23